We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Sensei Biotherapeutics Inc is a clinical-stage immunotherapy company. It is engaged in the discovery and development of next-generation therapies with an initial focus on treatments for cancer. The company's ImmunoPhage platform is a powerful, self-adjuvanted and highly differentiated immunotherapy ... Sensei Biotherapeutics Inc is a clinical-stage immunotherapy company. It is engaged in the discovery and development of next-generation therapies with an initial focus on treatments for cancer. The company's ImmunoPhage platform is a powerful, self-adjuvanted and highly differentiated immunotherapy approach that is designed to utilize bacteriophage to induce a robust, focused, and coordinated innate and adaptive immune response. Show more
- SNS-101 initial Phase 1 clinical data presented at SITC demonstrate potential best-in-class safety and pharmacokinetic profile, with no cytokine release syndrome or dose-limiting toxicities...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.72 | 69.2307692308 | 1.04 | 1.92 | 0.9712 | 994733 | 1.59384707 | CS |
4 | 0.79 | 81.4432989691 | 0.97 | 1.92 | 0.9101 | 321598 | 1.4701866 | CS |
12 | 0.97 | 122.784810127 | 0.79 | 1.92 | 0.74 | 158354 | 1.31373497 | CS |
26 | 0.98 | 125.641025641 | 0.78 | 1.92 | 0.5524 | 107088 | 1.1285753 | CS |
52 | 0.21 | 13.5483870968 | 1.55 | 1.92 | 0.51 | 66208 | 1.11098358 | CS |
156 | -11.49 | -86.7169811321 | 13.25 | 15.12 | 0.51 | 81700 | 4.24435142 | CS |
260 | -22.94 | -92.8744939271 | 24.7 | 26.38 | 0.51 | 91733 | 6.6113792 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions